Podcasts about crl

Labour's accusing the government of secretly spending $1 billion from next year's budget. The Taxpayers' Union has chimed in too, accusing the government of political skulduggery over the billion dollars in undisclosed future spending. It amounts to $22 million in '27, '28 before ramping up over a four year period. Heather du Plessis Allan asked the Prime Minister about it this morning and he said there's nothing to see here. "It's not actually that super exciting to be honest, Heather, because it's an issue that blew up as we were finalising the budget. It's about an accounting provision for an existing transport related issue.""CRL?""No, no, no. And it's just, but generally an accounting provision." So an accounting provision. And if it's not the CRL, it's bound to be the ferries surely. But why can't it be disclosed? Why, why even give Labour ammunition? And what's better, and I ask this as a genuine question, to have a secret stash of dosh under the mattress to spend at will later on transport issues, or to promise to pay for things and then work out how you'll get the money later? Like with Labour, they promised pay equity, which was going to cost billions and billions of dollars, school lunches, light rail. They promised all this in 2023 and said, oh, we'll find the money later, we'll make cuts and we'll find the money. So when National came in in '23 they inherited these promises that would be difficult to withdraw from, but the money wasn't there to pay for it. I'm getting really, really sick of governments, successive governments and government departments using money and then using boring paragraphs to try and hide where that money's gone, given that it's our money. And given that there doesn't seem to be a single sole source of truth. Nobody seems to agree on the figures and given that it's our money that they're spending, I really want to know. Like you put to Labour, and I would have put it to Labour, but they're announcing their list MPs today, so that's a step. Where's your policies? We were promised them after the budget, but maybe after the list MPs have been announced we'll see the policies. But you know, you put to Labour, you promised pay equity, you had no idea how to pay for it. You had no idea where the money was going to come from. And they'd say, oh well, and then they'd tell us how and it would be, you know, baffle them with bullshit. And I was just reading about the spat between the former Kāinga Ora CEO and Nicola Willis. She accused him of paying over the odds for property to the tune of $10 million. He was outraged, denied Willis's claim, said Kāinga Ora had not offered $10 million more than the next closest bid for a property. He told Parliament's Social Services Committee the gap had been less than $2 million, only for it to be later revealed it was more than $8 million. And I know that's a lot of numbers I'm throwing around, but bear with me because I think this stuff matters. I find it absolutely outrageous that the taxpayers were funding a purchase that was $2 million above the nearest commercial bid. So your average layman puts in a bid for this property and decides that that's what they think it's worth. Kāinga Ora using our money can go as high as it wants. But instead of going $100,000 higher, which they may have done if it was an auction, if it was a closed tender process, how are they so out of touch that they would offer what he thought was $2 million more and actually turned out to be $8 million more than what private buyers were thinking the property was worth? And everybody, I mean this is just kind of, I only found out about it reading a story on Newsroom. I didn't know about it. That's one deal. How many others have been done like this? I mean, is this common practice among developers that you can be $5 million, $6 million, $8 million out? I mean, I don't move in those circles, I don't know. All I know is that what that looks like is an errant disregard for the taxpayer's dollars. Our money. What you and I get up early for, to go to work for, to pay to the government and for the government to dole out to different government departments. How the hell can you pay $8 million more than the nearest bid for one property? One property. Where's the accountability and the financial scrutiny? Why don't we know what the $1 billion is being set aside for? Are there commercial sensitivities? How is Labour going to fund its promises given that it left the country nearly $7 billion in deficit and now we're even worse? I am really, really, really sick of paying taxes. I mean, we saw a lot of this where work was being duplicated or work was being done in the wrong place and oh, silly us, oops, you know, let's do it again because they've got endless money from us. Imagine the pay you could give to nurses. Imagine the hospitals that could be built if we weren't making these sorts of egregious, as I see it, accounting errors. But maybe in the rarefied atmosphere of commercial development, $8 million is neither here nor there. To me it is. It really is. It's my money and your money and I want to know what we're spending it on, looking at you National. I want to know how we're going to fund the promises you're making, looking at you Labour. And I want to know that you're being careful and judicious with my money, looking at you every single bloody government department. Who will ensure that this sort of financial insouciance will end? LISTEN ABOVE See omnystudio.com/listener for privacy information.

The Government says this year's budget especially strengthens Auckland's role as New Zealand's economic engine room. They point out that they're investing in health, including funding to purchase land for a future South Auckland Hospital, and a share of the Government's $5.5-billion health package. Additionally, they highlight plans for housing growth with a new $400-million fund for councils to enable more homes. Lastly, they're putting aside a billion for rail improvements, and another billion for school upgrades. But Mayor Wayne Brown says the devil is in the detail - and we'll need more clarity into a timeline of these initiatives, along with an explanation of how the Government's funding their share of the CRL. So what do these investments actually mean for Aucklanders - and how confident can we be in keeping a globally competitive city? Minister for Auckland Simon Watts talks to Tim Beveridge to discuss... LISTEN ABOVESee omnystudio.com/listener for privacy information.

On the Sunday Session with Francesca Rudkin Full Show Podcast for Sunday 10 May 2026, Francesca speaks to comedian and author Pax Assadi about his new book full of excerpts from his life, 'Mortified'. Aidan Donoghue from the Victoria University Wellington Student Association shares his thoughts on the Government's decision to scrap the fees free scheme. He says it's another kick in the guts for struggling students. Francesca gives her thoughts on the ex-CRL bosses' comments on the expensive project: Yes, it's over budget. But weren't you the guy making those decisions? And doctor Michelle Dickinson shares a research paper that asks the question, 'How do you give CPR in space?'. Get the Sunday Session with Francesca Rudkin Full Show Podcast every Sunday on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVESee omnystudio.com/listener for privacy information.

I can't wait to get onto Auckland's CRL. I can't wait to check out the overly grand stations. And I can't wait to experience moving around our city in a way residents of other modern cities around the world have been doing for decades. More so, I can't wait to see if it does what it was intended to do - transform the city's rail network from a "one-way cul-de-sac" into a two-way through-system, designed to double the network's capacity and improve accessibility across the region. It's been a monster of a ride getting this underground railway built, and yes it's costs a bundle, but I was intrigued this week that those most vocal about the decision making and costs are the people responsible for the project. Good on former CRL boss Sean Sweeney for coming out and calling it how he sees it. We need people with experience expressing views on how we do things in this country. Sweeney oversaw the CRL, and its many cost increases and associated challenges for six years, and admits he would do things differently if he had his time again. He feels the main issue with the CRL was that it was over-specified. It's not just the CRL, he also thinks the Christchurch stadium could have been built for less. As much as Cantabrians are enjoying the stadium, I'm sure there are many who feel the same way. Building infrastructure is a bit like buying a house. When you buy you're convinced you're being ripped off and then 7-10 years later you're generally pretty happy with the price and capital gain. I'm sure that over the next 10, 20, 100 years we'll feel pretty pleased with ourselves for future proofing these investments: a platform long enough to cope with extra train carriages in anticipation of Auckland's population growth, and a roof on Christchurch's stadium. Infrastructure Minister Chris Bishop took the opportunity to reinforce National's ‘fiscally responsible' stance by ordering a review into the build, while still trying to stay positive about a project which will open on his watch. It was a bit of a headline grab. An effort to look proactive in response to the criticism. But anything that costs $5.5 billion, and was as difficult and disruptive as the CRL has been, should be reviewed and learnt from. Preferably before we launch into a second Auckland Harbour crossing. Auckland Mayor Wayne Brown also piped up, expressing his long held view on the cost of the CRL, saying the project was “set up poorly” and he would take a tougher approach to projects. But weirdly, I don't hear Aucklanders talking about it the same way as those who were or are involved in it. Remember City Rail Link Limited was formed between the National Government and the Phil Goff-led Auckland Council in 2017 to jointly fund and oversee it through to completion. Both local and central Government are responsible for this project. While the CRL has been a torturous affair, especially for those living, working or trying to run a business around its construction, most locals just want it to open, for it to make a fundamental change to how we get around our clogged up city, and can't wait to give it a try. Spending $2 billion more on the CRL is worth a discussion, but maybe we need to keep it in perspective. Superannuation currently costs the country over $24 billion annually and is estimated by Treasury to cost over $45 billion in 10 years. The reluctance of political parties to thoughtfully address this is neglectful. So, enjoy the fancy infrastructure where you can, there's unlikely to be much more on the way. LISTEN ABOVE See omnystudio.com/listener for privacy information.

City Rail Link cost concerns are re-igniting calls for a shake up to the way we approach infrastructure. The project's former boss Sean Sweeney claims the build could've been completed at half the estimated $5.5 billion. It sparked Infrastructure Minister Chris Bishop to announce a full review of the project after it's opened later this year. Civil Contractors New Zealand CEO Alan Pollard told Mike Hosking Sweeney's views line up with broader over-spending concerns. He says we have a tendency to favour bespoke design, whereas having a catalogue of standard designs would be much more efficient. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Why now Sean? I had Covid vibes when I read Sean Sweeney's thinking about the CRL. It was Covid vibes because during that period I cannot tell you how many people I know and regularly dealt with, whether it was people in the media or people from business, who said one thing about the Government and their handling of lockdowns and the economy in private, and something completely different in public. So Sean, having left the CRL to head to Ireland, has now left Ireland but has stopped by long enough to tell us we don't scope our price major projects that well. Who knew? The CRL, at well over $5 billion, is a gargantuan waste of money. Yes, it will improve things and on paper it makes sense because it joins up some rail lines so you can go around and around. But like most things in life, convenience, improvement, or efficiency comes at a cost. What's a terrific idea at $50 is a waste at $200. And for something that started out about $2 billion and will come in at about $6 billion, the CRL has reached the stage where no one really wants to accept responsibility any more for the price and delays, because it got embarrassing a long time ago and tipped over into "well let's just make the most of it and hope it works". It won't of course. Not to the extent they dreamed, because what they dream of is New York and London, and we have never been that and never will be. Anyway, part of where Sean is right is ideology blinds common sense. Too many people want a say and before you know it, everything is a combination of delayed and expensive. Yes, the fast-track RMA reform will help. Less legal action will help. Fewer opportunities for review will help. And God forbid, cross party support would help. But what would also help is some backbone – people who say what they believe, whether it gets them attention, or into trouble, or not. There are too many pussies in places of influence. Too many spineless, scaredy cats who want the job, or the title, or the reputation, or the pay-packet, and just grin and bear it, or defend it, or lie about it, and babble nonsensical rubbish instead of being honest. As much as I appreciate Sean telling it like it is, and he's right and possibly someone in charge might take notice, what I would appreciate more was the same commentary before he filed the resignation letter and scarpered. See omnystudio.com/listener for privacy information.

City Rail Link cost concerns have uncovered a reoccurring issue with New Zealand infrastructure projects. The project's former boss Sean Sweeney has claimed the project could've cost half of its estimated $5.5 billion price. This sparked Infrastructure Minister Chris Bishop to announce a full review of the project after its open date later this year. Infrastructure NZ CEO Nick Leggett told Ryan Bridge we're not approaching projects right, from the start. He says we don't have the proper controls and take too long to plan, so things drag on. LISTEN ABOVE See omnystudio.com/listener for privacy information.

On the Early Edition with Ryan Bridge Full Show Podcast Friday 8th of May 2026, a new OECD report's calling for the age of eligibility for NZ super to rise, Informetrics CEO, Brad Olsen shares his thoughts. The Government's doing a review on why the CRL has cost so much, Infrastructure NZ CEO Nick Leggett tells Ryan what we can do to prevent huge cost blow outs of future projects. It's about to get easier for tourism businesses to use conservation land, Tourism Holdings Limited Chief Executive Grant Webster tells Ryan how big of an impact this will have. Plus, UK/Europe Correspondent Vincent McAviney has the latest on Get the Early Edition Full Show Podcast every weekday on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVE See omnystudio.com/listener for privacy information.

On this week's episode, Greg Suvannavejh, Josh Schimmer, Yaron Werber, Sam Fazeli, and special guest Financial Times journalist Oliver Barnes kick off by highlighting the strength of the biotech sector from a public markets perspective, noting the XBI has outperformed the S&P 500 so far this year. The group agrees biotech is in a solid position overall. In policy news, the co‑hosts discuss the latest on the Trump administration's proposed 100% pharma tariffs, Most Favored Nation drug pricing, and deals between big pharma and the administration. The conversation shifts to regulatory news, including changes to the CDC's ACIP charter, vaccine oversight concerns, and FDA Commissioner Dr. Marty Makary's press conference highlighting progress under his leadership. The group then highlights major deals, including Merck's $6.7 billion acquisition of Terns and details of the SEC filings, Gilead's $3.15 billion upfront deal for Tubulis, Neurocrine's $2.9 billion purchase of Soleno, and Garda Therapeutics' $125 million acquisition of Assertio. In breaking news, the co-hosts discuss Replimune's second CRL for its melanoma therapy. In data, the group highlights Ascendis' encouraging week‑52 achondroplasia data and Insmed's Phase 2 hidradenitis suppurativa results. The episode concludes with an update on the obesity landscape, including Lilly's newly approved oral GLP‑1, Novo's high‑dose Wegovy, and a Nature paper on GLP‑1 response variability. *This episode aired on April 10.

FIRST WITH YESTERDAY'S NEWS (highlights from Tuesday on Newstalk ZB) We're Just Blowing In the Global Winds/Thinking About Service Stations/Is Being Self-Employed Worth It?/This Train Set Better Be Good/Podcast RouletteSee omnystudio.com/listener for privacy information.

As far as conditions go ahead of a grand opening, you couldn't do much better than a petrol price spike for the City Rail Link. Construction and testing will be finished within three months. Then it's handed over to operators, who need another three months. So we can use it from September. Trains will depart every four to five minutes under the city. The cost? $5.5 billion. Half of that is funded by the Crown, so Gore — you've pitched in here. What's more, Wayne Brown reckons the operational costs mean what would have been a zero per cent rates increase this year will instead be seven per cent. So it's pretty bloody important — given the scale of the capital and operational spend, and the size of current petrol bills — that this thing happens: 1. As quickly as possible2. As conveniently as possible On the latter point, transport experts — train people — are sounding the alarm bells. That's because AT is talking about a transitional timetable for the first six months, meaning fewer trains than we were promised. On the Western Line, train spacing could mean commuters end up waiting longer for their service than they do currently under the old system. That would be a disaster. This thing needs to sing in full voice from day dot — that's when people will stress‑test it. First impressions are everything. If there's no material difference from day one, people may simply write it off. So the pressure is on to get the CRL up and running sooner — and then operate it faster than the speed of sound. Achieving the goal of transforming drivers into train riders depends on it. And conditions have never been better.See omnystudio.com/listener for privacy information.

This month: Multiple FDA regulatory decisions germane to dermatology, psoriasis and lupus; and Eosinophilic Fasciitis (EF) reminder and should you worry about fibromyalgia? Show Notes: 1. FDA Approves Icotrokinra for Plaque Psoriasis The FDA approved an oral IL-23 inhibitor, icotrokinra (Icotyde), for use in moderate-to-severe plaque psoriasis in adults and children 12 years of age and older who are candidates for systemic therapy or phototherapy, according to a https://t.co/q5b3TceFHx 2. FDA has approved secukinumab (Cosentyx) for use pediatric patients (aged 12yrs) with moderate to severe hidradenitis suppurativa  https://t.co/oX4LGU16QP 3. FDA has accepted the supplemental biologics license application for use of interleukin-23 inhibitor tildrakizumab (Ilumya; Sun Pharma) in active psoriatic arthritis (PsA) in adults. https://t.co/cwqz9DoWsL https://t.co/ut0A4MwqW7 4. TYK2 Inhibitor Deucravacitinib FDA Approved for Psoriatic Arthritis On Friday, March 6th, the FDA approved deucravacitinib (Sotyktu) for the treatment of adults with active PsA based on the results of the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical trials. https://t.co/a6rmortnoS 5.vUCB announced topline results of the BE-BOLD head-to-head study where bimekizumab (IL-17i) was superior to risankizumab (IL-23i) study; 553 active PsA in achieving an ACR50 response at 16 weeks. Enrolled PsA pts were either bilogic naïve or who had previous exposure to 1 TNFi 6. Retrospective TriNetX Network cohort study of adult PsA (N 123,031) pts, propensity- matched to non-PsA controls. PsA had signif higher CV morbidity: MACE (HR 1.74); mortality (HR 1.95); CHF (HR 1.96), MI (HR 1.71), & CVA (HR 1.49). bDMARDs reduced MACE (HR 0.95) & mortality (HR 0.92) vs csDMARDs   https://t.co/bHrq9KpwBM 7. Prevalence of fibromyalgia in PsA = 18%. FM-PsA pts have higher scores Dz activity scores from FM, rather than inflammation. Fibromyalgia is assoc w/ worse disease outcomes, including failure to achieve low disease activity state and poorer response to therapy. https://t.co/utQRXPmpDs 8. JAMA Patient Education Page on JAMA Eosinophilic Fasciitis (EF). EF is rare, but begins with swelling and redness of the arms and/or legs. Later the skin thickens and develops the peau d' orange appearance. EF does not involve fingers or toes, & doesnt have Raynauds https://t.co/WEFFITtmQC 9. REVEAL, a 5-yr real-world study of 236 SLE pts initiating anifrolumab (basekbube SLEDAI-2K 7 for mucocutaneous (67%) & MSK (49%) dz. At 6 months, 26% achieved remission, 66% reached LLDAS, and 57% achieved LLDAS5. Authors claim rapid onset of action https://t.co/16OQatOcPj https://t.co/mU9aciCNcH 10. Update on FDA complete response letter to AZ regarding BLA hold for anifrolumab (Saphnelo) for SC use in SLE. CRL originally issued 10/10/25, but announced 2/3/26. FDA CRL cites critical data quality w/ key analyses in SC-TULIP study. A BLA decision expected in 1st half of 2026 https://t.co/zuwtsdL6I9 11. NEJM: Obinutuzumab in Active Systemic Lupus Erythematosus https://rheumnow.com/news/nejm-obinutuzumab-active-systemic-lupus-erythematosus

Opposition leader, Chris Hipkins' weekly interview with Morning Report; The government is making changes to fuel supply standards to more closely align with Australia; Contact Energy boss responds to calls from Winston Peters to split the gentailers; Concerns airlines could cut New Zealand services by 80 percent; Will Auckland's new CRL live up to its expectations?

PhoneBoy features the following posts from the CheckMates community:Certificate and CRL validation fails from March 1, 2026Effective Network Management with SD-WAN January 2026: Video, Slides, and Q&ANano Agent / Nano Services in Quantum SD-WAN: the Control PlaneTech Tip - log ingestion problem (change log level to reduce log data)Session logs not showing Xlate informationCVE-2025-53057 and Check PointGA Announcement: API Request Step & Webhook Trigger are now available in PlayblocksR82.10 Video SeriesTroubleshooting Logging

The FDA is dominating the headlines once again thisweek.  Days after FDA Commissioner Marty Makary appeared to question uniQure's gene therapy candidate for Huntington's disease, the company revealed that the agency will require it to conduct a randomized, double-blind, sham surgery–controlled Phase 3 study. The FDA also published anothercomplete response letter (CRL), this one for REGENXBIO's gene therapy for Hunter syndrome. The rejection, sustained by the biotech early last month, was driven by issues with the study's population, controls and use of surrogate markers to measure efficacy, according to the document.  Meanwhile, regulatory experts have expressed concernsthat the FDA's circle of trust is shrinking, making many decisions feel like “fiat”—both in terms of individual drug applications and policy. The FDA has reportedly initiated a probe into complaints that a toxic workplace is fostered by CBER director Vinay Prasad, who is at the heart of many of these decisions. Finally, the biopharma industry continues to react to the agency's pivot from a requirement of two pivotal trials to one for approval, asking why now, what are the risks and what exactly the FDA expects from this one trial.   Still on the gene therapy front, Sarepta Therapeutics CEO Doug Ingram stepped down last week to spend more time with family as the company's muscular dystrophy mission hits home. Also during the company's fourth quarter earnings call, Sarepta projected that sales of its embattled Duchenne muscular dystrophy gene therapy Elevidys will be flat or down as far as 15% in 2026.  On the obesity front, Eli Lilly topped Novo Nordisk again in a weight loss trial, this time in a Lilly-sponsored study of patients with type 2 diabetes. But don't count Novo out yet. The company is actively seeking out new obesity assets, according to business development executive Tamara Darsow. Just last week, Novo linked with Boston'sVivtex to advance novel weight loss pills.Finally, check out BioPham Executive this week for a rundown of 2025's top-selling assets—spoiler: Merck's Keytruda held onto its crown as number one—and a story on former2seventy exec Chip Baird's new role as CEO of recently launched Poplar Therapeutics, which secured a $45 million series A extension this week.

You know how they say cranes in the sky is a good sign of growth? Well, not in Auckland. Not at Seascape. It's meant to be this city, this country, tallest tower. 187 metres tall. Beautiful expansive views of the water. 52 stories. A statement building for a city on the move. But for two years we've had this… construction stopped, half finished, beams and nuts and bolts exposed. Then yesterday the Chinese outfit developing it folded completely. Gone-ski. So what happens to this half-cooked tower down by the wharf? It's kind of hard to miss, you know. Imagine the Sky Tower with scaffolding on it for a year. Whatever happens needs to happen fast. Auckland is getting its mojo back. We've been talking all over the city lately, the areas your tourists venture, it's coming alive. The ICC, the CRL stations, the shops, Ponsonby, viaduct and waterfront; absolutely humming and heaving. There's a buzz in the air and it's not just politicians talking it up. Go and see if for yourself. It's happening. Even a lot of the road cones have disappeared. Someone out there will be eyeing a bargain, surely, and answer our prayers. Get in there and finish the job. Polish that turd and help make this city shine. See omnystudio.com/listener for privacy information.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES FDA sent a complete response letter to AstraZeneca on their application (BLA) for anifrolumabs (Saphnelo) subcutaneous use in SLE. Despite a positive TULIP-SC trial & EU approval of SC-anifrolumab, FDA & sponsor still have to work things out. CRL reasons are unknown https://t.co/3dNwEyolrj Review of Calcinosis Cutis - Surgical intervent. most effective (excision, curettage, laser ablation, etc). Medical measures inconsistently, partially effective, best if used early & localized (CCB, TCN, probenecid, immunomodulation, biologics, colchicine, NA thiosulfate, & JAKi https://t.co/rv0hQBv6nX Systematic Review of Targeted Rx for Systemic Sclerosis: from 32 RCTs & 2036 pts Rx w/ 23 targeted agents. Guselkumab had greatest effect on mRSS, followed by tofacitinib, inebilizumab, & baricitinib. For FVC, B-cell Rx (belimumab, RTX) had highest efficacy https://buff.ly/vHOSRws Dermatomyositis outcomes w/ 2475 pts (claims) & 1196 pts (EHR). Half had myositis panels & 35% had + MSAbs. Steroid use common in 69% & 74%. HCQ, MTX, MMF. Outocmes (per 1000PYs) wereL all-cause hospitalisation 92, malignancy 15.3, ILD 6.4, and myocarditis 2.1 https://t.co/DJqKGNGX76 Danish DERMBIO registry of psoriasis pts Rx w/ biologics. Among 3790 bionaive pts ustekinumab had best 1-5 yr survival vs (ADA & SEC). In 3403 bioexperienced pts, bimekizumab, guselkumab, & risankizumab had highest 2-year drug survival rate. https://t.co/TInyLPMYkb Real-world study of 1202 #PsA pts shows that secukinumab retention rates were lower w/ smoking (79%/73%/72% in never/former/current smokers) but not w/ obesity (72%/77%/77% in normal/overweight/obese), Adh HR signif. higher w/ former (1.32) & current smokers (1.27)   https://t.co/1REWmod73W Together PSO Trial - Combination Ixekizumab and Tirzepatide Today Lilly announced top line results of the TOGETHER-PsO open-label, Phase 3b trial demonstrating the significant benefits of concomitant ixekizumab (IXE: an IL-17A inhibitor) and tirzepatide (TIR: GLP-1agonist) over https://t.co/YWCjN2NyGM

The guys test each other's movie knowledge with a round of the classic CRL movie trivia game 28 Words Later. WATCH: https://youtu.be/PVJFzlY04Fg Follow Cinereelists: Facebook – Twitter – Instagram – TikTok Follow James: Letterboxd – BlueSky Follow Zach: Letterboxd – Twitter Follow Kyle: Letterboxd Support the show on Patreon. Subscribe: iTunes / RSS Have a film suggestion you think we've never seen and want us to discuss on the show? Send your pick to heyguys@cinereelists.com and one of us WILL watch it and discuss it on a future next show… or send a comment, suggestion or criticism and we'll discuss...

Five million dollars is being injected to revitalise one of Auckland's longest-standing shopping locations. The private capital will be used to overhaul the historic Queens Arcade, turning it into a boutique luxury retail precinct. Construction at the lower Queen Street site will begin in April and is due for completion in November. Queens Arcade Property Manager Ian Wright told Kerre Woodham the project has been over two years in the making, but they believe the timing is absolutely right. He says there's a lot of positive things happening in the CBD – foot traffic is returning, the new convention centre has opened, the CRL is opening soon, and cruise ships are still coming in. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Die voorsitter van die CRL - raad vir die regulering en beskerming van kulturele, godsdienstige en taalinstellings - het in Januarie 2026 bedank, omdat hy nie kan saamleef met die wete dat die staat kerke, predikante en die christelike geloof wil beheer en reguleer nie.  Wat staan christene te doen?  Huigelary vier hoogty, want die staat toon geen medelye of teenkanting teen die terroriste aanvalle en massamoorde op Iran se onskuldige burgers nie, terwyl daar wel ondersteunend vir goddeloses, vervolgers en verdrukkers opgetree en berig word.  Wat staan die kerk te doen?

A small tip on news coverage. The media can go some small way to redeeming its reputation by asking more questions. One of the current obsessions is the closure of hospitality outlets. A café only needs to announce their closing, and the media can't swoop fast enough with a doom and gloom headline. To be fair, The Hospitality Association doesn't help. They roll out no shortage of misery stories. Ruby in Auckland got headlines the other day after they announced they were leaving downtown Auckland. Now, Ruby isn't hospitality, but the same fetish for bad headlines applies. Get into the detail and, yes, the Auckland vibe isn't what it might once have been, but the real reason they were leaving is the space didn't suit them anymore. They were off elsewhere and days later their original space was snapped up by a business that was keen to expand. Fast forward to this week and it's the Rice Bowl Burger Bar in Wellington. Cue the Stuff headline: "Another Wellington hospo business announces closure". Here is what I know: every story has a story. It is not always the economy. In fact, often it isn't the economy. In some cases, it's wrong place i.e. they took the car parks away, or sometimes it's bad luck i.e. they built the CRL around you and didn't compensate you. Sometimes it's because you aren't very good at your job i.e. your food is crap and there are better places down the road. Sometimes it's about migration. Hospo is an easy way to buy work for you and the family, but that doesn't mean you're any good or understand the culture. But it is a ticket to work and a visa. The evidence, for those who want to look at it, shows hospo for those who work hard, offer good food and good service, does well. The country, sadly, is over hospo-ed. And irony of ironies, despite the closure and woe and misery headlines, we actually have more hospo outlets than we ever have. One closes, but at least another one, if not more, open. But they don't write about the start-ups. Because that would be just a bit too upbeat, wouldn't it? See omnystudio.com/listener for privacy information.

In this episode of the Consumer Finance Monitor Podcast, we examine one of the most closely watched and increasingly controversial developments in consumer finance: earned wage access (EWA) products. EWA products allow workers to access a portion of wages they have already earned before their scheduled payday. Proponents describe these products as a valuable financial tool that helps consumers manage cash-flow shortfalls without resorting to traditional payday loans. Critics, including the Center for Responsible Lending (CRL), argue that EWA products function as high-cost credit, often involving opaque fees that can trap consumers in cycles of debt. Our panel brings together industry and advocacy perspectives to explore the research, legal arguments, and regulatory uncertainty surrounding EWA, a market that has grown rapidly but remains unevenly regulated. Meet the Speakers ·        Alan Kaplinsky – Host and moderator. Founder and former Practice Group Leader of Ballard Spahr's Consumer Financial Services Group; now Senior Counsel. ·        Lucia Constantine – Senior Researcher at the Center for Responsible Lending, focusing on mortgage lending and predatory debt practices. ·        Yasmin Farahi – Deputy Director of State Policy and Senior Policy Counsel at CRL, specializing in small-dollar lending and state consumer protection initiatives. ·        Joseph Schuster – Partner in Consumer Financial Services Group at Ballard Spahr, with extensive experience advising on earned wage access products and their legal and regulatory treatment. Key Topics Covered in the Episode ·        What Is Earned Wage Access? An overview of EWA products, how they operate, and why they have become a focal point for regulators and consumer advocates. ·        Consumer Protection vs. Industry InnovationCRL presents research suggesting that EWA products operate as high-cost credit and may contribute to debt accumulation, while industry participants argue the products provide needed liquidity and differ fundamentally from traditional loans. ·        Fees, Tips, and Consumer Understanding A discussion of common pricing models, including expedited access fees and voluntary "tips," and whether consumers fully understand the true cost of using EWA services. ·        Research Findings CRL reviews studies conducted by it based on anonymized transaction data indicating frequent repeat usage, escalating fees, and increased overdraft activity among some users. ·        The Regulatory and Legal Landscape An examination of ongoing litigation, divergent state approaches, and federal regulatory ambiguity. While some states regulate EWA as credit, others have carved out exemptions. Courts are increasingly being asked to determine whether EWA products constitute "loans" under existing law. ·        Industry Responses and SafeguardsDiscussion of non-recourse structures, voluntary fee models, and industry-led efforts to mitigate consumer harm. ·        Policy Outlook Consideration of congressional interest, state-level reform efforts, and the likelihood of future regulatory intervention. Why This Episode Matters The debate over earned wage access is still in its early stages, but the outcome will have significant implications for fintech providers, employers, consumers, and regulators. This episode provides essential context and analysis for financial services professionals seeking to understand how EWA fits within existing consumer credit frameworks, and how that framework may change. Consumer Finance Monitor is hosted by Alan Kaplinsky, Senior Counsel at Ballard Spahr and founder and former chair of the firm's Consumer Financial Services Group. We invite you to subscribe on your preferred podcast platform for weekly insights into key developments in consumer financial services law and regulation. Since its recording, there have been a few developments relevant to this episode. For instance, on December 22, 2025, the Consumer Financial Protection Bureau issued an advisory opinion that states the Truth In Lending Act (TILA) does not apply to certain "earned wage access (EWA) products," and it rescinds a proposed interpretive rule issued under former CFPB Director Chopra that classified these products as credit subject to TILA with their fees considered finance charges. The Center for Responsible Lending expressed opposition to this latest advisory opinion. On January 13, 2025, the House Financial Services Committee held a hearing on financial technology that included consideration of draft legislation on "Earned Wage Access," which CRL refers to as "payday loan apps." Around 200 nonprofits have written to Congress about their opposition to the version of this bill as introduced last session of congress.

There's been growing debate over how Auckland's CBD can be revitalised after years of uncertainty and economic decline. The $5.5 billion City Rail Link is due to be built at the second half of the year and it's promised to bring in economic benefits, but it's unclear if it'll get the city in motion. Kiwi entrepreneur Andrew Barnes says a lot of shops and businesses have been closed, and it's not as attractive to prospective visitors. LISTEN ABOVESee omnystudio.com/listener for privacy information.

There's been growing debate over how Auckland's CBD can be revitalised after years of uncertainty and economic decline. The $5.5 billion City Rail Link is due to be built at the second half of the year and it's promised to bring in economic benefits, but it's unclear if it'll get the city in motion. Kiwi entrepreneur Andrew Barnes says a lot of shops and businesses have been closed, and it's not as attractive to prospective visitors. LISTEN ABOVESee omnystudio.com/listener for privacy information.

CRL Rights Commission Chairperson Thoko Mkhwanazi-Xaluva says complaints against Professor Musa Xulu surfaced at the end of October, with committee members accusing him of autocratic conduct and disruptive behaviour. She says she intervened, shut down a contentious WhatsApp group, and confronted Xulu directly. While he later reaffirmed support for self-regulation, concerns escalated over unauthorized draft documents using the CRL letterhead. Mkhwanazi-Xaluva says this caused public confusion, ultimately leading to Xulu's resignation as Section 22 chairperson. The CRL Rights Commission and the Section 22 Ad Hoc Committee for the Christian Sector were briefing the media in Braamfontein, Johannesburg. Updating the public on the status and significant matters related to the Section 22 Ad Hoc Committee's work, as well as the programs undertaken by the Commission in discharging its mandate. The briefing also addressed several issues surrounding the resignation of Reverend Professor Musa Xulu, who has since stepped down as the chairperson of Section Committee 22, established to probe abuses within the Christian Sector at the CRL Rights Commission.

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for December 28-January 3, 2025: 1. FDA Grants 510(k) Clearance to First Umbilical Cord–Derived Sheet Formulation for Wound Care The FDA granted 510(k) clearance to StimLabs' Theracor, marking the first umbilical cord–derived wound care device available in a sheet formulation. 2. FDA Approves Tradipitant (NEREUS) for the Prevention of Vomiting Induced by Motion The FDA approved tradipitant as the first new pharmacologic option in decades for preventing motion sickness–related vomiting. 3. FDA Issues Complete Response Letter for Relacorilant for Hypercortisolism The FDA issued a CRL for relacorilant, citing the need for additional evidence of effectiveness despite positive findings from completed trials. 4. FDA Issues Complete Response Letter for ONS-5010 for Wet AMD The FDA again declined approval of ONS-5010 for wet AMD, reiterating that confirmatory evidence of efficacy is required to support the application. 5. FDA Accepts, Grants Priority Review to AXS-05 sNDA for Alzheimer's Disease Agitation The FDA accepted and granted Priority Review to the sNDA for AXS-05, advancing a potential new treatment option for agitation in Alzheimer's disease.

Auckland Mayor Wayne Brown defends his annual $235 million operating cost calculation for the City Rail Link as scepticism arises. He told Heather du Plessis-Allan, "most of when you pay your rates, is paying things off. They're not free. "It's not free to have a road. It's not free to have a train. It's not free to have a bus." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Join Jonathan Guiney and Brendon Russ on Reliability Radio as they speak with Sheldon Roper, a CRL Black Belt and Reliability Engineer at JLL. Sheldon shares his unique career path from working on offshore rigs to becoming a reliability engineer and achieving his Black Belt in a remarkably short two and a half years. This conversation demystifies the prestigious Black Belt certification, explaining that it's not about new, complex projects, but about providing a "proof of concept" by documenting the valuable work you do every day. Sheldon offers practical advice for anyone on the fence about pursuing the certification: just set aside the time to write up the projects you're already completing. The discussion highlights the importance of certifications for professional growth and demonstrates how they serve as a powerful tool for showing tangible value to clients and your organization.

Chalked Cast and chill with the Chalked Squad - Support this podcast: ⁠https://podcasters.spotify.com/pod/show/chalked-cast/support⁠TIMESTAMPS:0:00 - Intro, NRG winning Worlds2:32 - Where has CJ been? Johnny ignores a fan, Garrett broke a record?10:45 - Worlds Recap, NRG being World Champions14:21 - Worlds Play-ins and Group Stage recap27:35 - Worlds Playoffs recap54:47 - Do we need to change the Grand Final Format?1:03:13 - The Transfer Window, Dralii to Falcons, Trk511 to Twisted Minds1:15:52 - Stizzy to Vitality, Juicy to Karmine Corp, AppJack and Seikoo to Geekay1:29:15 - MENA Roster recap , M0nkeyM00n to Twisted Minds, New Gentle Mates roster, EU rumoured rosters 1:37:33 - NA Rosters, Firstkiller LJ Kofyr to Shopify Rebellion, New SSG and GenG Rosters, Retals retires 1:55:39 - Should pro players be allowed in CRL?1:59:13 - SAM, OCE, APAC and SSA roster recaps2:06:12 - Outro / What to look forward to next week!

So, while we were on a break, I went to Christchurch to see my son for his 19th birthday. It was a fleeting visit. I flew down on a Friday and home on Saturday afternoon, but my goodness – Christchurch turned it on. The weather was stunning, the views of the Alps made you want to drop everything and run for the slopes. People were out-and-about. The city was humming – Friday lunch time around Oxford Terrace and Cashel St was bustling – but in a relaxed way. There are wonderful new precincts filled with interesting shops and eateries and new architectural landmarks. Eating was my son's first priority, and once that was taken care of we spent the days cruising second-hand book and vinyl shops from the central city to glistening Lyttleton. I can't say what it's like to live in Christchurch 2.0. I can't begin to imaging what it's been like living through the rebuild, and there's clearly still plenty of recovery work to be completed, but from a visitor's point of view it felt alive, thriving and positive. My uber driver told me tourism was starting to build again and I can see why. My few days on the mainland were a stark contrast with my journey into Auckland's city centre yesterday. Now, I am a proud Aucklander and I have pushed back at the complaints about central Auckland. I enjoy shopping and going to events in the city, but goodness, it's hard sometimes. Yesterday we attended the University of Auckland's Open Day. The campus was busy and it was uplifting and exciting to see so many young people on the cusp of new adventures. But all the positively was drained from us when we went to head home. We'd parked in Victoria Street Carpark in the heart of the city. When it came to leave at 12.05 we think someone forgot to put the carpark full sign out so cars kept flooding in, and with only one lane taking cars both up and down the full carpark building, traffic came to a grinding halt. Stuck on the 13th level, we didn't move for more than 40 minutes. Finally, at around 1pm, we exited the building. There may have been another reason, maybe a technical glitch somewhere, but when I asked the AT man who was directing traffic I was sternly instructed to get moving. I suspect he'd coped a bit of abuse from a lot of angry customers and was under a bit of pressure. Here's the crazy thing is – the parking cost us $2.50. How good would that have been if we could have exited the building! It seems finding affordable and efficient parking, and good access to the city when events are on, is becoming harder. These kind of issues are unhelpful for a city centre with a reputational problem. Nor does it motivate people to come back. We don't know exactly what impact of the CRL will have on moving people around the city when it opens next year, but fingers crossed it helps – a lot. Aucklander's also deserve a thriving inner city which makes us feel invigorated, rather than frustrated. Yesterday we sorted out my daughter's degree and her future in a shorter period of time than it took for us to get out of a carpark building. Now, that's just nuts. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Join Jonathan Guiney and Brendon Russ on Reliability Radio as they welcome John Fortin and Billy Appleton from the Beverly Salem Water Board. This episode tells the inspiring story of a small utility (18 employees, 4 in maintenance) serving 100,000 residents, and their incredible journey from outdated, verbal maintenance practices to winning an Uptime Award for sustainability. John and Billy detail their strategic adoption of the Uptime Elements framework, transforming operations that once relied on 1990s paper records into a structured system. A key focus is their proactive approach to succession planning and onboarding new talent, integrating the "language of reliability" (Uptime Elements, CRL) into job descriptions and training. Billy shares his first-time experience at the conference, highlighting the invaluable power of the Reliabilityweb community for learning and peer-to-peer sharing from diverse organizations. The discussion underscores how strategic alignment, cross-collaboration, and continuous learning are vital for even the smallest teams to achieve significant impact, including preparing for an upcoming $8.5 million plant upgrade.

On the Saturday Morning with Jack Tame Full Show Podcast for Saturday 9 August 2025, Australian idol legend Guy Sebastian joins Jack in studio for a chat about releasing album number ten, and gives a very special performance of a brand new track. Jack considers his experiences with the NYC subway compared to Auckland's new CRL. A hearty recipe for the weekend, Rosa Flanagan of Two Raw Sisters shares a how-to for her Slow Cooked Moroccan Lamb and Pumpkin dish. Ruud Kleinpaste reckons it's about getting warm enough to get back into the garden. Plus, Catherine Raynes shares details on a brand new Kiwi tale of resilience, The Unlikely Doctor by Timoti Te Moke. Get the Saturday Morning with Jack Tame Full Show Podcast every Saturday on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVESee omnystudio.com/listener for privacy information.

When I first moved to New York, I spent my first year living in a railroad apartment above an Ecuadorian fruit shop on Second Avenue. It was a character-building experience. I went weeks without heating or hot water in winter, and my windows had almost no effect whatsoever in keeping out the ceaseless sound of trucks thundering past my bedroom enroute to restock the city. When I arrived they'd just start construction on the Second Ave subway, a few blocks from my home. The project was hitting a few speedbumps. Bedrock turned out to be deeper than anticipated, a worker nearly died after being stuck in waste-deep slop on site, and what was supposed to be a controlled explosion sent rocks flying all over a busy Manhattan intersection. Curiously, the Second Ave subway route was first proposed in the 1920s, which Wikipedia tells was about the same time that planners first mused over the possibility of the Morningside Deviation, a train tunnel in central Auckland. Stage One of the Second Avenue subway was a 3.2km tunnel. The Central Rail Link is 3.5km. Second Ave ended up costing more than $7 Billion. The Central Rail Link blew out however many times but at last check was $5.5 Billion. The weird thing about a big underground tunnel development is that most of us never fully appreciate the scale of the work. It's obvious I suppose, but even if you live and work in the city, while you get used to a few cones and traffic delays up above the ground, you have no real perspective about the extraordinary activities happening somewhere beneath your feet. Auckland Transport has this week released its updated transit map with the CRL stations. Apparently they've done 1600 test runs so far. They've run trains more than 5000km – Kaitaia to Bluff two-and-a-half times. They've been driving trains at 70kmph directly underneath Auckland's CBD and at no point have I felt so much of a rumble or a shudder. I reckon the vast majority of us up top have been absolutely none-the-wiser. The kid in me who briefly considered becoming an engineer (and even volunteered to spend a school holiday touring the Lyttelton Tunnel) can't help but think that's pretty cool. After riding along on a VIP tour yesterday with all the politicians and movers-and-shakers, Auckland Mayor Wayne Brown was in vintage form. How was it? He was asked. “It was a ride in a train.” He said. “We don't want excitement.” Well, maybe not. But guilty as charged. Maybe it's the engineering. Maybe it's the people-watching. Maybe it's the broader sense of momentum and life, but whether it's a tube, an underground, or a subway, I love a bit of subterranean mass-transit. You know you're a nerd when you're less excited about the opening of New Zealand's first IKEA than the transport connection you'll take to get there. After years of construction, the Second Ave subway opened two weeks before I moved back home. One of the last things I did on my last few days in New York was ride a loop. Not because I had somewhere to be but because I wanted to see what all that fuss and money and effort had created, out of sight, underneath my feet. I can't wait to do the same thing here. See omnystudio.com/listener for privacy information.

A glimpse of a new era in Auckland Transport has been unveiled today. At Britomart Station an updated map gives commuters a preview of the new stations and rail-lines they will use when the long-awaited Central Rail Links opens. The over-budget and over-time CRL is nearing completion, but officials aren't ready yet to say exactly when it will open. Finn Blackwell has more.

A vast change to what's been promised for Auckland City Rail Link's opening capacity. In 2022, it was reported 27 thousand peak passengers would be using the rail line from opening day next year. That's now gone down to 19 thousand passengers an hour at peak times. AT Public Transport Director Stacey van der Putten told Mike Hosking the 27 thousand figure merged a few different elements including design capacity, timetabling, and patronage. She points out that 19,000 is still a significant increase on current numbers, as it's still a 50% increase in patronage. Van der Putten told Hosking it will take some effort to rebuild confidence in the rail network after the prolonged disruption, but there's plenty of enthusiasm for the new line. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Not everyone's a fan of Government's efforts to build taller in central Auckland suburbs. The Government is requiring the council to legislate for apartments at least 15 storeys high around the Mount Eden, Kingsland, and Morningside Stations. It will be 10 storeys near the Mount Albert and Baldwin Avenue terminals. Albert-Eden Local Board Chair, Kendyl Smith, says this feels rushed, and hasn't included any consultation with residents. "So to be told overnight that you might have a 15-storey block beside you is very unpalatable." LISTEN ABOVESee omnystudio.com/listener for privacy information.

The Government's instructed Auckland Council to allow apartments at least 15 storeys high near key City Rail Link train stations. Density requirements around the Mt Albert and Baldwin Ave stations require at least 10 storey apartments, and requirements around the Maungawhau, Kingsland, and Morningside rail terminals have been increased from six storeys to 15. Simeon Brown and Chris Bishop say it will ensure Auckland takes economic advantage of the transformational investment in the city. AUT Future Environments Professor John Tookey told Mike Hosking that even the proposition of consenting a 15 storey building in the middle of a city isn't a five minute undertaking. His suspicion is it will take at least a decade to see any kind of measurable mass urban densification around the stations. He also told Hosking that the Government's interference in running Auckland is likely to cause significant political issues. Tookey says NIMBY-type arguments will likely crop up: why here, who's going to fund it, and how will it impact everyone else in the area? LISTEN ABOVE See omnystudio.com/listener for privacy information.

An Auckland councillor says the Government requiring larger apartments in the neighbourhood of new CRL train stations is in line with other council requests. The Government's announced Resource Management Bill amendments to allow apartments 10 and 15 storeys high around some central city terminals. Councillor Richard Hills says it ties into requests to remove medium-density residential housing rules. "We've also asked if we can downzone or restrict some areas in flooding and hazard zones - this change will legally allow us to do that, but on the proviso that we increase capacity elsewhere." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Join Jonathan Gagne and Brendan Russ on Reliability Radio as they sit down with passionate industry experts Dave Reiber from Reliabilityweb and Rich McInnes from Net Results. This episode dives deep into the urgent issue of the skilled trades gap – a "big hole that's getting bigger." Dave and Rich reveal the motivation behind their upcoming book, designed to be a conversation for everyone in the trades, from aspiring apprentices to seasoned leaders and organizational decision-makers. Hear fascinating historical insights on the origins of trades and guilds, and how artisans have shaped our world for millennia. Beyond the challenges, the discussion celebrates the pride, craftsmanship, and artistry of tradespeople, highlighting the often-overlooked value and legacy they create. Dave shares his personal journey from an electrician at General Motors to a global business manager, emphasizing the vast opportunities a trade career can unlock. Rich challenges the notion that AI will diminish the need for skilled hands, making a compelling case for the enduring importance of those who "bend pipe or solder a joint." They explore critical questions: How do we foster aspirational goals in the trades? What does "master of the master" truly mean? And how can we bridge the perception gap between college degrees and vocational skills, showing the incredible ROI of a trade career? This conversation is a powerful call to action, reminding us that tradespeople are the unsung heroes building our future, and they need our recognition and support.

For the last five years the route 64 bus fare has been virtually free at just one cent to tag on, but come Sunday a full fare will apply. The bus service was originally established to accomodate for the closure of the Mount Eden railway station and the city's CRL project. But with 1.1 million passengers using the service since it began, it's quickly become a cost-effective staple for those wanting to get around Mount Eden, Grafton and Kingsland. Reporter Louise Ternouth hopped onboard for one of its last days as a one cent ride.

Season 7 of the ICC Pulse Podcast is here, and to kick things off we're exploring the ins and outs of the International Code Council's code development process – just in time for the 2025 Committee Action Hearings (April 27 - May 6, 2025)! Learn what the process entails, how it shapes the building safety codes we rely on and discover how you can get directly involved.   Our expert guests, including our very own Russ Manning and Beth Tubbs from the Code Council's Technical Services team, discuss the structure of a typical code cycle, where to access proposed code changes and why your participation in this process is so important. Guests on the show:   Russ Manning, PhD, LEED AP, CRL, CEFP, Senior Vice President (SVP), Technical Services, International Code Council  Beth Tubbs, PE, FSFPE, Vice President of Codes, Technical Services, International Code Council  Jeffrey M. Shapiro, P.E., FSFPE, President of International Code Consultants, Executive Director of the Texas Fire Protection Association and works with Lake Travis Fire Rescue  John Terry, Retired, Assistant Director of Codes and Standards, State of New Jersey Links to related and referenced topics in this episode:   Learn more and register for the 2025 Committee Action Hearings.   Learn more about Code Council's code development process.  Read about the benefits of participating in the code development process.   Learn about the current code development cycle.   View the Code Council's codes and standards.  

The almost three and a half kilometre long inaugural journey was made at a crawl; about five kilometres an hour overnight, meaning the loop took two and half hours in total while various underground checks were completed. The train ran south from Waitemata Station at Britomart under central Auckland past the new underground stations at Te Waihorotiu and Karanga-a-Hape to Maungawhau Station on the Western/North Auckland Line. Wayne Cooney, the Systems Director for the CRL spoke to Lisa Owen.

Chalked Cast and chill with Speed and the Chalked Squad - Support this podcast: https://podcasters.spotify.com/pod/show/chalked-cast/support 0:00 - Intro 1:16 - Speed still has it 3:34 - How does Speed juggle CRL and RLCS, why did Speed come to NA? 11:04 - Chess, League of Legends and living in NA 25:17 - Karmine Corp Domination, EU RLCS recap 40:30 - SSG Abomination, NA RLCS recap 42:52 - Spacestation Gaming vs Lotus8 drama 53:35 - Buchholz system, NA RLCS Predictions 1:10:38 - Patreon Questions

In summary – 2/3 of CRL are sick, no show again this week but we'll be back soon.

Jonathan C. Thomas, PE, CEM, CRL is President at Building Maintenance Optimization Consultants, Inc. (BMOC) where he is passionate about supporting FM organizations that manage portfolios of buildings for their full life cycles. Mike Petrusky asks Jon how organizations can use a systems approach that leads to better data-driven decision making in the FM industry. They explore how the enhancement of CMMS content including asset, preventive and predictive maintenance, OEM, installation, and design data are essential in the future of the built environment. Tune in to hear the insights and practical advice you will need to be an Asset Champion in your organization! Connect with Jon on LinkedIn: https://www.linkedin.com/in/jonathancthomaspe/ Learn more about BMOC: http://www.buildingmoc.com/ Watch the full video of this episode: https://www.youtube.com/playlist?list=PLSkmmkVFvM4E39sM-pNaGhLoG0dkM947o Learn more about Eptura™: https://eptura.com/ Discover free resources and explore past interviews at: https://eptura.com/discover-more/podcasts/asset-champion/ Connect with Mike on LinkedIn: https://www.linkedin.com/in/mikepetrusky/  

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Kerstin Dolph, Senior Vice President of Manufacturing at Charles River Laboratories. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kerstin, covering: The value of having managers and mentors guide you and champion your success Navigating transitions from finance to operations and research to biologics manufacturing while becoming a senior leader at CRL Tackling the task of integrating testing and manufacturing at CRL globally to cut timelines for clients The importance of staying close and connected to the patient so you never lose sight of the impact of the work done in this space Stabilizing signs in the biotech market and pivoting to the market's needs in creative ways Kerstin joined Charles River 2001 in a Finance role for the Company's Research Models and Services (RMS) business in Germany. She transitioned to the U.S. RMS business in 2009 and was promoted to Senior Finance Director of Global RMS in 2015. In 2017, Ms Dolph was promoted to Corporate Vice President of North American RMS, responsible for leading the Company's North American RMS business. This included managing several consolidation and efficiency initiatives and global RMS technology enhancements. In 2019, Ms Dolph assumed the role of Corporate Vice President of Global Biologics. Subsequently, she assumed responsibility for the Company's CDMO business and was promoted to senior vice president of biologics solutions in October 2021. Ms. Dolph is currently the Senior Vice President of Manufacturing. She is responsible for driving each business's strategic direction and future growth within the Company's Manufacturing Solutions segment, including Biologics Testing Solutions, CDMO, and Microbial Solutions. Ms. Dolph holds a bachelor's degree from the International Accountancy & Business School in Wuerzburg, Germany and was recognised by the Bavarian Government for outstanding performance.   This episode of Molecule to Market is sponsored by Vetter, a global leader in aseptic filling solutions for injectable products in the pharmaceutical and biotech industries. Discover more about Vetter's comprehensive services, from early-stage development to commercial production, and how they support clients in delivering high-quality therapies to the market. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

Well, in this episode we have 2 very interesting and challenging clinical situations. These come from real world clinical encounters so we thought we would share these with you because they are brain teasers and should be discussed. They both have to do with OB ultrasound. First, is there a “minimal” CRL to estimate gestational age? In other words, is there a CRL that is too small to be accurate? It's an intriguing question and we will give an answer! Second, in women with regular and predictable menstrual cycles that are every 21 or 35 days, how to we “reconcile” a CRL EGA since that CRL algorithm is based on a “typical 4-week cycle”? How can we? Should we adjust the sono dating? WE will review in this episode. PLUS, we will review the latest data on how AI can greatly impact gestational age calculation via ultrasound. So, we have 2 questions, and we will give 2 answers (2 x2)…Listen in for details.

Revocation Update GRC's next experiment Patch Tuesday "The Famous Computer Café" IsBootSecure GRC Email Working through WiFi Firewalls Transferring DNS OCSP attestation vs. TLS expiration Platform key expiration National Public Data Show Notes - https://www.grc.com/sn/SN-988-Notes.pdf Hosts: Steve Gibson and Leo Laporte Download or subscribe to this show at https://twit.tv/shows/security-now. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit You can submit a question to Security Now at the GRC Feedback Page. For 16kbps versions, transcripts, and notes (including fixes), visit Steve's site: grc.com, also the home of the best disk maintenance and recovery utility ever written Spinrite 6. Sponsors: bitwarden.com/twit vanta.com/SECURITYNOW threatlocker.com for Security Now joindeleteme.com/twit promo code TWIT

Revocation Update GRC's next experiment Patch Tuesday "The Famous Computer Café" IsBootSecure GRC Email Working through WiFi Firewalls Transferring DNS OCSP attestation vs. TLS expiration Platform key expiration National Public Data Show Notes - https://www.grc.com/sn/SN-988-Notes.pdf Hosts: Steve Gibson and Leo Laporte Download or subscribe to this show at https://twit.tv/shows/security-now. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit You can submit a question to Security Now at the GRC Feedback Page. For 16kbps versions, transcripts, and notes (including fixes), visit Steve's site: grc.com, also the home of the best disk maintenance and recovery utility ever written Spinrite 6. Sponsors: bitwarden.com/twit vanta.com/SECURITYNOW threatlocker.com for Security Now joindeleteme.com/twit promo code TWIT

Revocation Update GRC's next experiment Patch Tuesday "The Famous Computer Café" IsBootSecure GRC Email Working through WiFi Firewalls Transferring DNS OCSP attestation vs. TLS expiration Platform key expiration National Public Data Show Notes - https://www.grc.com/sn/SN-988-Notes.pdf Hosts: Steve Gibson and Leo Laporte Download or subscribe to this show at https://twit.tv/shows/security-now. Get episodes ad-free with Club TWiT at https://twit.tv/clubtwit You can submit a question to Security Now at the GRC Feedback Page. For 16kbps versions, transcripts, and notes (including fixes), visit Steve's site: grc.com, also the home of the best disk maintenance and recovery utility ever written Spinrite 6. Sponsors: bitwarden.com/twit vanta.com/SECURITYNOW threatlocker.com for Security Now joindeleteme.com/twit promo code TWIT